NU65PS923777
Cooperative Agreement
Overview
Grant Description
Capacity Building Assistance (CBA) for HIV prevention programs to end the HIV epidemic in the United States - Project abstract summary:
The University of Rochester, Infectious Diseases Division, Center for Community Practice (UR-CCP) in Rochester, New York requests CDC-RFA-PS-24-0020 funding to provide capacity building assistance (CBA) services for Component D: Technical Assistance for high-impact HIV prevention programs.
This funding will allow UR-CCP to build upon its current CDC-funded CBA program.
The purpose of this program will be to strengthen capacity for the nation’s HIV workforce through tailored TA services to address programmatic challenges to optimally plan, integrate, implement, evaluate, and sustain HIV prevention and surveillance programs and services.
Daniela Dimarco, MD, MPH (PI/Associate Medical Director) and Juhua Wu, MA, CPC (Co-PI, Director) will continue to be primarily responsible for oversight of the CBA services including mentoring, skills building, consultations, demonstration, information sharing, resource development and sharing, summits, and supporting reciprocal learning among peers.
TA will be customized to meet CDC-funded program needs.
The focus population is the national interdisciplinary HIV prevention workforce within current and future CDC-funded HDS and CBOs and their local partners who provide services to populations disproportionately impacted by HIV, including: gender diverse persons; Black and Latinx persons; all races/ethnicities of gay, bisexual, or other MSM; and people who use drugs, exchange sex, have history of incarceration, live in rural areas, are American Indian/Alaskan Native, or people with HIV over age 50.
UR-CCP will continue to utilize existing faculty/staff and consultants with over 30 years’ programmatic experience and expertise providing culturally responsive HIV/STI/VH care, prevention, and other public health services regionally and nationally to meet the needs of impacted populations and inform CBA services.
UR-CCP will utilize current long-term CBA relationships with HDS and CBOs to maintain communication, assess programmatic needs, and provide tailored reactive TA.
UR-CCP will work collaboratively with other CBAs and CDC to implement annual CBA plans and optimize provision of CBA services.
State-of-the-art technology will be used to maximize efficiencies and broaden coverage.
UR-CCP will continue to collaborate with other regional and national training and TA organizations to maximize resources and avoid duplication.
UR-CCP will continue its active participation in the CBA provider network to share resources and identify emerging trends.
Over the five-year program, UR-CCP will continue to be responsive to CDC re-direction of its programmatic activities to address current and emergent needs both within and across components.
UR-CCP will collaborate with CDC to finalize an evaluation and performance management plan and use the results to guide continuous quality improvement.
UR-CCP will demonstrate achievement of the outcomes of strengthening and enhancing HD and CBO organizational capacity to support comprehensive HIV programs to diagnose, treat, and prevent HIV and syndemic conditions, and address SDOH inequities; building a national highly skilled HIV workforce that promotes and supports the reduction of new HIV infections, increased access to care and improved health outcomes for people with HIV, reduction of HIV-related health disparities and health inequities, and a coordinated national response to end the HIV epidemic.
The University of Rochester, Infectious Diseases Division, Center for Community Practice (UR-CCP) in Rochester, New York requests CDC-RFA-PS-24-0020 funding to provide capacity building assistance (CBA) services for Component D: Technical Assistance for high-impact HIV prevention programs.
This funding will allow UR-CCP to build upon its current CDC-funded CBA program.
The purpose of this program will be to strengthen capacity for the nation’s HIV workforce through tailored TA services to address programmatic challenges to optimally plan, integrate, implement, evaluate, and sustain HIV prevention and surveillance programs and services.
Daniela Dimarco, MD, MPH (PI/Associate Medical Director) and Juhua Wu, MA, CPC (Co-PI, Director) will continue to be primarily responsible for oversight of the CBA services including mentoring, skills building, consultations, demonstration, information sharing, resource development and sharing, summits, and supporting reciprocal learning among peers.
TA will be customized to meet CDC-funded program needs.
The focus population is the national interdisciplinary HIV prevention workforce within current and future CDC-funded HDS and CBOs and their local partners who provide services to populations disproportionately impacted by HIV, including: gender diverse persons; Black and Latinx persons; all races/ethnicities of gay, bisexual, or other MSM; and people who use drugs, exchange sex, have history of incarceration, live in rural areas, are American Indian/Alaskan Native, or people with HIV over age 50.
UR-CCP will continue to utilize existing faculty/staff and consultants with over 30 years’ programmatic experience and expertise providing culturally responsive HIV/STI/VH care, prevention, and other public health services regionally and nationally to meet the needs of impacted populations and inform CBA services.
UR-CCP will utilize current long-term CBA relationships with HDS and CBOs to maintain communication, assess programmatic needs, and provide tailored reactive TA.
UR-CCP will work collaboratively with other CBAs and CDC to implement annual CBA plans and optimize provision of CBA services.
State-of-the-art technology will be used to maximize efficiencies and broaden coverage.
UR-CCP will continue to collaborate with other regional and national training and TA organizations to maximize resources and avoid duplication.
UR-CCP will continue its active participation in the CBA provider network to share resources and identify emerging trends.
Over the five-year program, UR-CCP will continue to be responsive to CDC re-direction of its programmatic activities to address current and emergent needs both within and across components.
UR-CCP will collaborate with CDC to finalize an evaluation and performance management plan and use the results to guide continuous quality improvement.
UR-CCP will demonstrate achievement of the outcomes of strengthening and enhancing HD and CBO organizational capacity to support comprehensive HIV programs to diagnose, treat, and prevent HIV and syndemic conditions, and address SDOH inequities; building a national highly skilled HIV workforce that promotes and supports the reduction of new HIV infections, increased access to care and improved health outcomes for people with HIV, reduction of HIV-related health disparities and health inequities, and a coordinated national response to end the HIV epidemic.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
New York
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 274% from $929,187 to $3,474,643.
University Of Rochester was awarded
HIV Prevention CBA for Ending Epidemic in US
Cooperative Agreement NU65PS923777
worth $3,474,643
from National Center for HIV, Viral Hepatitis, STD, and TB Prevention in August 2024 with work to be completed primarily in New York United States.
The grant
has a duration of 4 years 7 months and
was awarded through assistance program 93.834 Capacity Building Assistance (CBA) for High-Impact HIV Prevention.
The Cooperative Agreement was awarded through grant opportunity Capacity Building Assistance (CBA) for HIV Prevention Programs to End the HIV Epidemic in the United States.
Status
(Ongoing)
Last Modified 4/20/26
Period of Performance
8/30/24
Start Date
3/31/29
End Date
Funding Split
$3.5M
Federal Obligation
$0.0
Non-Federal Obligation
$3.5M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU65PS923777
Additional Detail
Award ID FAIN
NU65PS923777
SAI Number
NU65PS923777-743477646
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVJ0 CDC NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TUBERCULOSIS PREVENTION
Awardee UEI
F27KDXZMF9Y8
Awardee CAGE
03CZ7
Performance District
NY-90
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Modified: 4/20/26